Physician profile
Michael Jolly
NPI 1639295462
$280,542.04
in general payments reported to CMS, 2019-2025
29 companies · $26K in 2025
The $26K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $46K · 2021: $36K · 2022: $48K · 2023: $31K · 2024: $48K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $70K · Consulting Fee: $23K · Travel and Lodging: $6,978 · Food and Beverage: $5,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $69,503.90 |
| Consulting Fee | $22,887.34 |
| Travel and Lodging | $6,978.16 |
| Food and Beverage | $5,358.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $232,167.22 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $16,352.39 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Boston Scientific Corporation | $9,898.45 | 2019-2025 | Avvigo Guidance System, Eluvia |
| Medtronic, INC. | $5,422.41 | 2022-2025 | Mo.Ma Ultra, Endurant Iis |
| W. L. Gore & Associates, INC. | $3,480.69 | 2019-2025 | Product In Development, Gore Tag Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Contego Medical, INC | $2,774.30 | 2024 | Neuroguard |
| Inquis Medical, INC. | $2,500.00 | 2024-2025 | Aventus |
| Vesper Medical | $1,541.39 | 2021-2022 | |
| Angiodynamics, INC. | $1,196.61 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Silk Road Medical, INC. | $937.16 | 2019 | |
| Abbott Laboratories | $688.10 | 2019-2025 | Esprit, Portico, Emboshield Nav6 |
| Biotronik INC. | $583.07 | 2021-2024 | Orsiro Mission, Pk Papyrus, Nhancer Rx |
| Penumbra, INC. | $532.88 | 2022-2024 | Indigo System |
| Philips North America LLC | $459.52 | 2020-2024 | (6554) Peripheral Vascular Undivided |
| Cook Medical LLC | $443.52 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $336.46 | 2021-2023 | Impella |
| Medtronic Vascular, INC. | $236.72 | 2019 | |
| Argon Medical Devices, INC. | $210.56 | 2022 | |
| Mercator Medsystems, INC. | $200.18 | 2022 | |
| Cardiovascular Systems INC. | $199.33 | 2021 | |
| Centerline Biomedical INC. | $172.65 | 2021 | |
| Abbvie INC. | $54.94 | 2020-2021 | |
| Edwards Lifesciences Corporation | $46.26 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $36.93 | 2025 | Wegovy |
| Imperative Care, INC | $30.46 | 2024 | Symphony Catheter |
| Teleflex LLC | $15.88 | 2019 | |
| Siemens Medical Solutions USA, INC. | $12.59 | 2019 | |
| Cardinal Health 200 LLC | $11.37 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jolly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.